José is a science news writer with a PhD in Neuroscience from Universidade of Porto, in Portugal. He has also studied Biochemistry at Universidade do Porto and was a postdoctoral associate at Weill Cornell Medicine, in New York, and at The University of Western Ontario in London, Ontario, Canada. His work has ranged from the association of central cardiovascular and pain control to the neurobiological basis of hypertension, and the molecular pathways driving Alzheimer’s disease.
Decreased blood oxygen levels during the six-minute walk test (6MWT) is a risk factor for osteoporosis in patients with non-cystic fibrosis (CF) bronchiectasis, according to a study. The findings ... Read more
A third-party evaluation (TPE) confirmed the efficacy of the bronchiectasis treatment candidate Apulmiq found in Phase 3 trials, Aradigm, the developer of the therapy, recently announced. Apulmiq, previously known as Linhaliq ... Read more
Bronchiectasis has a “highly personal” impact on patients’ quality of life, a U.K study reports, but a number of factors are of particular impact, including an ability to control symptoms ... Read more
Impaired antibacterial activity of neutrophils in bronchiectasis patients may be why they are so susceptible to chronic lung infections, according to researchers from the U.K. Their study, “Blood Neutrophils ... Read more
Bronchiectasis is associated with frequent chronic obstructive pulmonary disease (COPD) exacerbations and hospitalizations, a recent study shows. The study, “Relationship between the presence of bronchiectasis and acute exacerbation in ... Read more
An antibiotic-resistant Pseudomonas aeruginosa infection worsens bronchiectasis, but does not increase patients’ death rates, a Chinese study shows. The research, “Antibiotic-resistant Pseudomonas aeruginosa infection in patients with bronchiectasis: prevalence, risk factors and prognostic ... Read more